Yahoo
OTC Markets OTCPK - Delayed Quote USD

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

2.2000 +0.0250 (+1.15%)
As of October 30 at 4:00:00 PM EDT. Market Open.
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
42,731,256.7232
41,661,612.7482
41,067,195.8626
41,399,539.5884
43,951,546.8952
Cost of Revenue
20,894,588.7489
20,800,103.1922
21,365,573.9724
21,595,308.7569
23,169,690.4197
Gross Profit
21,836,667.9743
20,861,509.5559
19,701,621.8902
19,804,230.8315
20,781,856.4756
Operating Expense
18,498,234.1548
17,715,355.5599
16,498,479.8457
18,240,906.7705
17,145,016.8264
Operating Income
3,338,433.8194
3,146,153.9960
3,203,142.0445
1,563,324.0610
3,636,839.6492
Net Non Operating Interest Income Expense
-977,105.5354
-1,001,267.5976
-1,097,160.9280
-997,350.0838
-709,762.3803
Pretax Income
5,153,412.8075
5,111,983.2639
4,169,281.6797
3,264,567.8787
4,574,381.5848
Tax Provision
714,458.8537
864,053.6355
656,841.2947
369,504.4522
626,917.4647
Net Income Common Stockholders
3,514,759.2254
3,370,561.5626
2,769,886.6314
2,386,265.8137
3,730,804.5828
Basic EPS
1.33
1.27
1.04
0.89
1.43
Diluted EPS
1.33
1.27
1.04
0.89
1.43
Basic Average Shares
2,642,721.9360
2,653,985.4820
2,663,352.5300
2,681,197.5440
2,608,954.2540
Diluted Average Shares
2,642,721.9360
2,653,985.4820
2,663,352.5300
2,681,197.5440
2,608,954.2540
Total Operating Income as Reported
5,250,609.0345
5,228,351.3396
4,245,103.9093
3,307,507.9051
4,656,656.3813
Total Expenses
39,392,822.9038
38,515,458.7522
37,864,053.8181
39,836,215.5274
40,314,707.2461
Net Income from Continuing & Discontinued Operation
3,514,759.2254
3,370,561.5626
2,769,886.6314
2,386,265.8137
3,730,804.5828
Normalized Income
3,245,341.2134
3,809,445.6277
2,729,556.1322
3,072,203.2105
6,069,937.7516
Interest Income
258,689.8937
300,503.6642
373,210.3052
363,645.3862
282,634.6393
Interest Expense
1,212,983.0341
1,265,350.7209
1,431,914.6821
1,324,830.5256
963,806.9182
Net Interest Income
-977,105.5354
-1,001,267.5976
-1,097,160.9280
-997,350.0838
-709,762.3803
EBIT
6,366,395.8417
6,377,333.9848
5,601,196.3618
4,589,398.4044
5,538,188.5030
EBITDA
6,366,395.8417
9,890,367.5588
8,602,739.3494
7,554,583.0343
7,874,099.7482
Reconciled Cost of Revenue
20,894,588.7489
20,800,103.1922
21,365,573.9724
21,595,308.7569
23,169,690.4197
Reconciled Depreciation
3,153,607.2705
3,513,033.5740
3,001,542.9876
2,965,184.6299
2,335,911.2451
Net Income from Continuing Operation Net Minority Interest
3,514,759.2254
3,370,561.5626
2,769,886.6314
2,386,265.8137
3,730,804.5828
Total Unusual Items Excluding Goodwill
312,781.4004
-528,155.6409
47,872.4742
-773,485.3654
-2,710,623.1662
Total Unusual Items
312,781.4004
-528,155.6409
47,872.4742
-773,485.3654
-2,710,623.1662
Normalized EBITDA
6,053,614.4413
10,418,523.1998
8,554,866.8753
8,328,068.3997
10,584,722.9144
Tax Rate for Calcs
0.0001
0.0002
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
43,363.3883
-89,271.5758
7,541.9749
-87,547.9686
-371,489.9974
12/31/2022 - 4/21/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: